Drug Composition Age-Related Indication Year of Approval
Doxil/Caelyx PEGylated liposomal formulation of doxorubicin Various Cancers 1995
Ontak Denileukin diftitox Cutaneous T-cell lymphoma 1999
Visudyne liposomal formulation of verteporfin Wet age-related macular degeneration 2000
Eligard Leuprolide acetate and PLGH polymer formulation Advanced prostate cancer 2002
Estrasorb™ Micellar Estradiol Vasomotor symptoms in Menopause 2003
Macugen PEG-anti-VEGF aptamer Neovascular age-related macular degeneration as a cause of blindness in aged people 2004
Abraxane® Albumin-bound paclitaxelnanoparticles Breast Cancer 2005
Renvela Sevelamer carbonate; and Sevelamer HCl Chronic kidney disease 2007
Cimzia® Certolizumab pegol Rheumatoid arthritis 2009
Abraxane® Albumin-bound paclitaxelnanoparticles Pancreatic Cancer 2013
Onivyde® Liposomal Irinotecan Pancreatic Cancer 2015
Zilretta Triamcinolone acetonide Osteoarthritis knee pain 2017